Broad spectrum antiviral fractions from the lichen Ramalina farinacea (L.) Ach.

Abstract:

BACKGROUND:An ethylacetate-soluble fraction (ET4) from the lichen Ramalina farinacea has previously been shown to inhibit the infectivity of lentiviral and adenoviral vectors, as well as wild-type HIV-1. We now determined the antiviral activity of ET4 against other wild-type viruses, including the herpes simplex virus type 1 (HSV-1) and the respiratory syncytial virus (RSV). METHODS:Wild-type HIV-1, HSV-1 or RSV were pre-incubated with various concentrations of ET4 for 30 min at 37 degrees C before adding to P4CCR5 indicator cell line (HIV-1), ELVIS TM indicator cell line (HSV-1) or HEp2 cell line (RSV) in 96-well microtitre plates. Controls contain virus alone without ET4. The anti-HIV and anti-HSV activities were quantified by estimating beta-galactosidase expression of the respective indicator cell lines while the anti-RSV activity was determined via an immunofluorescent technique, employing monoclonal mouse antibody against the P-protein of RSV. Toxicity of ET4 to cell lines was evaluated in parallel using either the BrdU incorporation method or the MTT method. The effect of ET4 on the enzymatic activity of HIV-1 reverse transcriptase was also evaluated using a chemiluminescent reverse transcriptase assay. Bioassay-guided fractionation of the whole methanol extract of R. farinacea involved sequential screening of HPLC fractions using a vector-based assay technique. RESULTS:ET4 inhibited HSV-1 and RSV potently (IC(50)=6.09 and 3.65 microg/ml, respectively). Time-of-addition studies suggest that both entry and post-entry steps of the HIV-1 replication cycle and the entry step of the RSV replication cycle are targeted. Furthermore, ET4 inhibited HIV-1 reverse transcriptase with an IC(50) of 0.022 microg/ml. Bioassay-guided fractionation of ET4 led to the identification sub-fraction rfO, with activity against lentiviral vector and HIV-1 (RNA viruses) but not against HSV-1 (DNA virus) and sub-fraction rfM, with activity against HSV-1 but not against the lentiviral vector. CONCLUSIONS:ET4 represents a novel fraction from the lichen R. farinacea with broad spectrum antiviral activity against DNA viruses (adenovirus and HSV-1) and RNA viruses (HIV-1 and RSV). The effect against DNA and RNA viruses is mediated by different sub-fractions within R. farinacea.

journal_name

Chemotherapy

journal_title

Chemotherapy

authors

Esimone CO,Grunwald T,Nworu CS,Kuate S,Proksch P,Uberla K

doi

10.1159/000194974

subject

Has Abstract

pub_date

2009-01-01 00:00:00

pages

119-26

issue

2

eissn

0009-3157

issn

1421-9794

pii

000194974

journal_volume

55

pub_type

杂志文章
  • Therapeutic effects of cefozopran on polymicrobial infections associated with Enterococcus faecalis in a Rat pyometra model.

    abstract::Enterococcus faecalis plays an important role as a pathogen in polymicrobial infections. We evaluated the efficacy of cefozopran (CZOP) using polymicrobial pyometra rats. Rats were infected with a mixed intrauterine inoculation of E. faecalis plus either Bacteroides fragilis or Prevotella bivia (minimal inhibitory con...

    journal_title:Chemotherapy

    pub_type: 杂志文章

    doi:10.1159/000007100

    authors: Mikamo H,Kawazoe K,Sato Y,Izumi K,Tamaya T

    更新日期:1998-03-01 00:00:00

  • Phase II trial of XELOX as first-line treatment for patients with advanced gastric cancer.

    abstract:BACKGROUND:The prognosis of patients with advanced gastric cancer (AGC) remains poor, and no single chemotherapy regimen is recognized as a global standard. A phase II trial was conducted to determine the efficacy and tolerability of capecitabine and oxaliplatin (XELOX) given every 3 weeks in combination in patients wi...

    journal_title:Chemotherapy

    pub_type: 杂志文章

    doi:10.1159/000305256

    authors: Luo HY,Xu RH,Wang F,Qiu MZ,Li YH,Li FH,Zhou ZW,Chen XQ

    更新日期:2010-01-01 00:00:00

  • Penetration of clarithromycin into human saliva.

    abstract::The concentrations of clarithromycin after a single oral dose of 500 mg were determined in serum and saliva of ten healthy adult volunteers. After 2 h, the levels were 4.04 +/- 1.14 (SD) mg/l in serum and 2.72 +/- 0.87 mg/l in saliva. After 7 h these values were 1.98 +/- 0.65 and 1.21 +/- 0.34 mg/l, respectively, and ...

    journal_title:Chemotherapy

    pub_type: 杂志文章

    doi:10.1159/000239139

    authors: Wüst J,Hardegger U

    更新日期:1993-09-01 00:00:00

  • Comparative pharmacokinetics of ceftriaxone after subcutaneous and intravenous administration.

    abstract::The pharmacokinetics of ceftriaxone (CRO) after subcutaneous and intravenous administration was studied in 10 healthy volunteers (5 males, 5 females, age 22-43 years, body weight 64.3 +/- 9.5 kg). Each of them received 2.0 g CRO i.v., and then 0.5 g i.v. and 0.5 g CRO s.c. in a randomized cross-over design. Subcutaneo...

    journal_title:Chemotherapy

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1159/000238342

    authors: Borner K,Lode H,Hampel B,Pfeuffer M,Koeppe P

    更新日期:1985-01-01 00:00:00

  • Phase II trial of neoadjuvant cisplatin, 5-fluorouracil and interferon-alpha in operable squamous cell carcinoma of the esophagus.

    abstract:BACKGROUND:The combination of 5-fluorouracil (5-FU), cisplatin and interferon (IFN)-alpha was found to result in a high response rate in advanced esophageal squamous cell carcinoma (SCC). METHODS:Resectable cases of esophageal SCC were treated with 3 cycles of chemotherapy consisting of cisplatin 70 mg/m(2) i.v. on da...

    journal_title:Chemotherapy

    pub_type: 杂志文章

    doi:10.1159/000151353

    authors: Bazarbashi S,Abdelsalam M,Amin T,El-Bassiouni M,Soudy H,Elweshi A,Alhusseiny H,Rehman K,Memon M,Ajarim D

    更新日期:2008-01-01 00:00:00

  • A case of hemiballism as a rare side effect of ciprofloxacin in a patient with liver cirrhosis.

    abstract:BACKGROUND:Ciprofloxacin is commonly used and considered to be relatively safe in patients with cirrhosis, especially in the treatment of enteric and urinary tract infections. Among the adverse effects of ciprofloxacin, neurologic complications are rare. METHODS/RESULTS:We report a case of hemiballism and altered ment...

    journal_title:Chemotherapy

    pub_type: 杂志文章

    doi:10.1159/000218098

    authors: Kim SH,Jeong SH,Kim JW,Lee SH,Kim JM

    更新日期:2009-01-01 00:00:00

  • Association between antibiotic resistance and the expression of Dr adhesin among uropathogenic Escherichia coli.

    abstract:BACKGROUND:Urinary tract infections (UTIs) are a significant health problem and Escherichia coli has been exported to be the primary pathogen in approximately 80% of cases. E. coli express structures called adhesins, fimbriae or pili that help them bind to specific tissue receptors. One such adhesin is Dr, which binds ...

    journal_title:Chemotherapy

    pub_type: 杂志文章

    doi:10.1159/000048507

    authors: Kachroo BB

    更新日期:2001-03-01 00:00:00

  • Single intramuscular dose of ceftriaxone as compared to 7-day amoxicillin therapy for acute otitis media in children. A double-blind clinical trial.

    abstract::Fifty-two children (mean age 23 months) with acute otitis media were treated randomly with either a single intramuscular dose of ceftriaxone (Rocephin) 50 mg/kg (27 patients) or 7 days of amoxicillin 12.5 mg/kg t.i.d. (25 patients). The rate of resolution of acute symptoms and incidence of recurrences and relapses dur...

    journal_title:Chemotherapy

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1159/000238646

    authors: Varsano I,Frydman M,Amir J,Alpert G

    更新日期:1988-01-01 00:00:00

  • Antibacterial effects of meropenem and imipenem against Haemophilus influenzae.

    abstract::Phase contrast microscopy, killing curves and turbidimetric growth curves were used in a comparative study of the antibacterial effects of imipenem and meropenem on Haemophilus influenzae. The minimal inhibitory concentrations (MICs) and their ranges of meropenem and imipenem using five beta-lactamase-producing strain...

    journal_title:Chemotherapy

    pub_type: 杂志文章

    doi:10.1159/000238830

    authors: Yourassowsky E,Van der Linden MP,Crokaert F

    更新日期:1991-01-01 00:00:00

  • Cefodizime modulates in vitro tumor necrosis factor-alpha, interleukin-6 and interleukin-8 release from human peripheral monocytes.

    abstract::Among third-generation cephalosporins, cefodizime (CFDZ) has shown to modulate many functions of the host defense system against infections. The aim of the present study was to assess the in vitro CFDZ-dependent modulation of interleukin (IL)-6, tumor necrosis factor-alpha (TNF-alpha) and IL-8 release from lipopolysac...

    journal_title:Chemotherapy

    pub_type: 杂志文章

    doi:10.1159/000239358

    authors: Meloni F,Ballabio P,Bianchi L,Grassi FA,Gialdroni Grassi GG

    更新日期:1995-07-01 00:00:00

  • Therapeutic activity of pretazettine on Ehrlich ascites carcinoma: adjuvant effect on standard drugs in ABC regimen.

    abstract::A narcissus alkaloid, pretazettine hydrochloride (PTZ), has been shown to be active against Ehrlich ascites carcinoma. The Ehrlich cells are more sensitive to PTZ in DBA/2 mice than in Swiss mice. The therapeutic activity of the individual standard drugs in ABC (adriamycin, BCNU, and cyclophosphamide) regimen against ...

    journal_title:Chemotherapy

    pub_type: 杂志文章

    doi:10.1159/000237992

    authors: Furusawa E,Lum MK,Furusawa S

    更新日期:1981-01-01 00:00:00

  • Pharmacokinetics and antibacterial efficacy in vivo of beta-lactam combinations against Proteus vulgaris.

    abstract::The pharmacokinetics and antibacterial efficacy of mezlocillin, cefotaxime, cefoperazone and the mezlocillin/cefalosporin combinations, respectively, were studied by adopting the granuloma pouch model in rats. Exudate concentrations of mezlocillin were higher after combined i.v. injection with a cefalosporin as determ...

    journal_title:Chemotherapy

    pub_type: 杂志文章

    doi:10.1159/000238136

    authors: Dalhoff A,Gehl AE,Gau W,Lode H

    更新日期:1982-01-01 00:00:00

  • Heterogeneity of beta-lactamase production in Pseudomonas maltophilia, a nosocomial pathogen.

    abstract::Twenty Pseudomonas maltophilia isolates were examined for susceptibility to beta-lactam antibiotics, including carbapenems, and for beta-lactamase production. All the isolates were resistant to imipenem (MICs 64-512 mg/l) and to a lesser extent, to meropenem (MICs 16-256 mg/l). None of the isolates produced significan...

    journal_title:Chemotherapy

    pub_type: 杂志文章

    doi:10.1159/000238757

    authors: Cullmann W,Dick W

    更新日期:1990-01-01 00:00:00

  • Cost-effectiveness of ceftriaxone and amikacin as single daily dose for the empirical management of febrile granulocytopenic children with cancer.

    abstract::In children undergoing anticancer chemotherapy, a granulocytopenic febrile episode is a life-threatening condition. Prompt initiation of empirical broad-spectrum antibiotics is essential to limit morbidity and mortality. To evaluate the cost-effectiveness of combination antibiotics consisting of a third generation cep...

    journal_title:Chemotherapy

    pub_type: 杂志文章

    doi:10.1159/000239590

    authors: Pession A,Prete A,Paolucci G

    更新日期:1997-09-01 00:00:00

  • Low endotoxin release from Escherichia coli and Bacteroides fragilis during exposure to moxifloxacin.

    abstract:BACKGROUND:Bacterial endotoxin is known to act as a potent trigger of disseminated coagulation and septic shock. During clinical antibiotic treatment, endotoxin may be released from Gram-negative bacteria. It is known that antibiotic classes differ in their ability to induce endotoxin release. AIM:It was the aim of th...

    journal_title:Chemotherapy

    pub_type: 杂志文章

    doi:10.1159/000321622

    authors: Trautmann M,Scheibe C,Wellinghausen N,Holst O,Lepper PM

    更新日期:2010-01-01 00:00:00

  • Pharmacokinetics of oral co-trimazine and the penetration of its components sulfadiazine and trimethoprim into peripheral human lymph.

    abstract::Five healthy informed male volunteers received oral doses of 820 mg sulfadiazine (SDZ) plus 180 mg trimethoprim (TMP) (co-trimazine) every 24 h. Concentrations in serum, peripheral lymph from the leg and urine were determined after the first dose, and on the 4th day to reflect approximate steady-state conditions. TMP ...

    journal_title:Chemotherapy

    pub_type: 杂志文章

    doi:10.1159/000238418

    authors: Bergan T,Engeset A,Olszewski W

    更新日期:1986-01-01 00:00:00

  • The effect of the doxycycline-rifampicin and levamisole combination on lymphocyte subgroups and functions of phagocytic cells in patients with chronic brucellosis.

    abstract:BACKGROUND:Brucellosis is one of the important health problems for both humans and animals in Turkey since agriculture and stock raising appears to be the most important means of subsistence. Investigations on the pathogenesis of brucellosis reveal that the etiologic agent can survive in phagocytic cells, and cell-medi...

    journal_title:Chemotherapy

    pub_type: 杂志文章

    doi:10.1159/000084020

    authors: Dizer U,Hayat L,Beker CM,Görenek L,Ozgüven V,Pahsa A

    更新日期:2005-03-01 00:00:00

  • Adenosylmethionine decarboxylase inhibitors--lack of activity against cytopathic effects of HIV.

    abstract::Many bis(amidinohydrazones) are potent inhibitors of adenosylmethionine decarboxylase (AdoMetDC), a key enzyme of polyamine biosynthesis, and some of them are also known to be powerful antiviral agents. Therefore, seven bis(amidinohydrazones), including the two most potent inhibitors of eukaryotic AdoMetDC so far repo...

    journal_title:Chemotherapy

    pub_type: 杂志文章

    doi:10.1159/000238790

    authors: Elo H

    更新日期:1990-01-01 00:00:00

  • Effect of probenecid on the pharmacokinetics of DQ-2556, a new 3-quaternary ammonium cephalosporin antibiotic, in humans.

    abstract::A total of 5 healthy volunteers were enrolled in a crossover study on the dose dependency and the effect of probenecid on pharmacokinetics of DQ-2556. They were administered intravenously 0.5 and 1.0 g of DQ-2556, and 1.0 g of DQ-2556 with oral administration of probenecid. The linearity in pharmacokinetics of DQ-2556...

    journal_title:Chemotherapy

    pub_type: 杂志文章

    doi:10.1159/000239029

    authors: Shiba K,Yoshida M,Shimada J,Saito A,Matsubayashi K,Hashimoto S,Yoshida K,Osada Y,Sakai O

    更新日期:1992-01-01 00:00:00

  • Antimicrobial activity of subinhibitory concentrations of aminoglycosides against Pseudomonas aeruginosa as determined by the killing-curve method and the postantibiotic effect.

    abstract::This investigation used the postantibiotic effect (PAE) and killing curves to provide data on the antimicrobial activity of subinhibitory (1/8x, 1/4x and 1/2x minimum inhibitory concentration; MIC) and inhibitory (1x MIC) concentrations of amikacin, gentamicin and tobramycin against Pseudomonas aeruginosa. Subinhibito...

    journal_title:Chemotherapy

    pub_type: 杂志文章

    doi:10.1159/000238842

    authors: Zhanel GG,Karlowsky JA,Hoban DJ,Davidson RJ

    更新日期:1991-01-01 00:00:00

  • Cefepime resistance and associated risk factors among Escherichia coli strains isolated from clinical specimens.

    abstract::Cefepime is active against bacteria producing chromosomally and plasmid-mediated extended broad-spectrum β-lactamase enzymes. The aim of this study was to evaluate risk factors for acquisition of cefepime resistance in Escherichia coli strains among hospitalized patients in a university hospital in Sanandaj, Iran. The...

    journal_title:Chemotherapy

    pub_type: 杂志文章

    doi:10.1159/000323623

    authors: Mansouri M,Ramazanzadeh R,Norabadi P

    更新日期:2011-01-01 00:00:00

  • Micro test for assaying sensitivity of Plasmodium vivax in vitro.

    abstract::A modified Rieckmann test was developed for assessing chloroquine sensitivity of Plasmodium vivax strains. This test envisages the evaluation of parasite growth with different concentrations of the drug and its comparison with controls, at the end of a 48-hour experimental period. Using this test, 16 strains were asse...

    journal_title:Chemotherapy

    pub_type: 杂志文章

    doi:10.1159/000238664

    authors: Renapurkar DM,Pradhan VR,Sutar NK,Deshmukh RA,Pandit CH,Marathe SN

    更新日期:1989-01-01 00:00:00

  • A Novel Approach of Synthesizing and Evaluating the Anticancer Potential of Silver Oxide Nanoparticles in vitro.

    abstract:BACKGROUND:Development of novel strategies to kill cancer by sparing normal cells is of utmost importance. Apart from their known antimicrobial activity, only limited information has been recorded regarding the antitumor potential of biocompatible silver oxide nanoparticles (AgONPs). There is a need to evaluate the ant...

    journal_title:Chemotherapy

    pub_type: 杂志文章

    doi:10.1159/000453446

    authors: Banerjee K,Das S,Choudhury P,Ghosh S,Baral R,Choudhuri SK

    更新日期:2017-01-01 00:00:00

  • Renal sparing by amphotericin B colloidal dispersion: clinical experience in 572 patients.

    abstract::Data from five clinical trials of amphotericin B colloidal dispersion (ABCD) in the treatment of invasive mycoses were pooled to analyze the renal sparing effects of ABCD. Serum creatinine levels at baseline and either during or at end of treatment were available for 499 of 572 patients (87.2%). The median cumulative ...

    journal_title:Chemotherapy

    pub_type: 杂志文章,评审

    doi:10.1159/000048469

    authors: Gurwith M,Mamelok R,Pietrelli L,Du Mond C

    更新日期:1999-06-01 00:00:00

  • Experience of gemcitabine plus oxaliplatin chemotherapy in patients with advanced biliary tract carcinoma.

    abstract:BACKGROUNDS:The combination gemcitabine-oxaliplatin (GEMOX) is frequently used in patients with advanced biliary tract carcinoma (BTC). However, this is only based on phase II studies performed in selected patients.We assessed the efficacy and safety of the GEMOX regimen in non-selected patients with advanced BTC. MET...

    journal_title:Chemotherapy

    pub_type: 杂志文章

    doi:10.1159/000316848

    authors: Hollebecque A,Bouché O,Romano O,Scaglia E,Cattan S,Zerbib P,Heurgue A,Lagarde S,Mariette C,Triboulet JP,Pruvot FR,Hebbar M

    更新日期:2010-01-01 00:00:00

  • Antibacterial effects of niridazole. I. Effect on infection of mice with Salmonella typhimurium.

    abstract::Niridazole was shown to be an effective chemotherapeutic agent for mice infected intravenously with a niridazole-sensitive strain of Salmonella typhimurium. Death rates as well as bacterial counts per spleen were reduced, even in compromised animals. Histologic examination of spleens proved the reduction of inflammato...

    journal_title:Chemotherapy

    pub_type: 杂志文章

    doi:10.1159/000238069

    authors: Hof H,Müller KM,Heine WD

    更新日期:1982-01-01 00:00:00

  • Clinical Practice of Adjuvant Chemotherapy in Patients with Early-Stage Epithelial Ovarian Cancer.

    abstract:BACKGROUND:Adjuvant platinum-based chemotherapy improves survival in women with early-stage epithelial ovarian cancer (EOC). Yet, there is a wide variety in clinical practice. METHODS:All patients diagnosed with FIGO I and IIa EOC (2006-2010) in the south of the Netherlands were analyzed. The percentage of patients th...

    journal_title:Chemotherapy

    pub_type: 杂志文章

    doi:10.1159/000445024

    authors: Frielink LM,Pijlman BM,Ezendam NP,Pijnenborg JM

    更新日期:2016-01-01 00:00:00

  • Effect of hydrocortisone and BCNU on long-term murine bone marrow cultures.

    abstract::Hydrocortisone (HC) has been observed to influence an in vitro Dexter culture system with maintenance of pluripotent hematopoietic stem cells (CFU-s) and progenitor cells (CFU-gm, BFU-e). In the present study, a two-phase murine Dexter culture system was established to study the mechanism of HC-mediated suppression of...

    journal_title:Chemotherapy

    pub_type: 杂志文章

    doi:10.1159/000238340

    authors: Horikoshi A,Murphy MJ Jr

    更新日期:1985-01-01 00:00:00

  • Perioperative antibiotic prophylaxis in bile-duct interventions: results of two prospective randomized studies.

    abstract::The success of perioperative prophylaxis in gallbladder surgery was examined in two prospective randomized studies with a total of 326 patients. Postoperative wound-healing impairments did not occur in any of the patients receiving a single preoperative application of an antibiotic with a high biliary elimination rate...

    journal_title:Chemotherapy

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1159/000238511

    authors: Harnoss BM,Hirner A,Dibbelt H,Häring R,Rodloff R,Lode H

    更新日期:1987-01-01 00:00:00

  • Vancomycin plus imipenem ceftazidime or ciprofloxacin in second line therapy in patients with febrile neutropenia not responding to first line therapy.

    abstract::137 patients with febrile neutropenia after cytotoxic therapy not responding to ceftazidime plus or ceftriaxone plus netilmicin in received additionally to the previous combination either vancomycin alone or combined with another anti-gram-negative compound: imipenem in those treated prophylactically with ofloxacin an...

    journal_title:Chemotherapy

    pub_type: 杂志文章

    doi:10.1159/000239434

    authors: Lacka J,Oravcova E,Sevcikova L,Studena M,Bachanova V,Kukuckova E,Spanik S,Sufliarsky J,Helpianska L,Trupl J,Kunova A,Vochyanova I,Sycova Z,Grey E,Krcméry V Jr

    更新日期:1996-03-01 00:00:00